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Abstract
The accumulation of amyloid-beta (Aβ) oligomers is believed to be the driving force
behind Alzheimer’s disease (AD) pathogenesis. Due to the metastable nature of Aβ oligomers,
the knowledge of Aβ aggregation and accumulation is not well understood. Here, we use
capillary electrophoresis (CE) and photo-induced crosslinking of unmodified proteins (PICUP)
to learn about the aggregation of Aβ.
First, we explore the effect of capillary coating on Aβ1-42 protein loss using CE. The
dynamic coatings tested were PHEA and 50 kDa, 2000 kDa, 5000 kDa, and 8000 kDa PEO. The
covalent coating tested was PVA. The results indicated that 2000 kDa PEO allowed for the best
recovery of Aβ1-42 with 87%. This was better than the uncoated capillary recovery of 66%, but
less than the optimal 90%. The biggest issue encountered was a protein recovery of greater than
100%, which is theoretically impossible. More procedure development should be done to solve
this problem.
Next, the PICUP reaction was optimized for analysis of Aβ1-42. Using a novel approach,
the goal was to apply PICUP to capture Aβ1-42 oligomers and correlate bands via SDS-PAGE
analysis to peaks via CE analysis. The results showed that reactants needed for successful
PICUP application interfered with CE detection of Aβ1-42. We tested alternate reactants and
several methods of removing reactants after PICUP application. We learned that dialysis was the
most promising method of Aβ1-42 detection via CE after PICUP.
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Chapter 1: Introduction
Alzheimer’s disease (AD), a neurodegenerative disorder and most common form of
dementia, is characterized by progressive memory loss, ultimately ending in death. (1)
Approximately 500,000 people die each year from AD, making it the 6th leading cause of death
in the United States. Additionally, AD is the only cause of death in the top ten that cannot be
prevented, slowed, or cured. Between 2000 and 2010, Alzheimer’s deaths increased by 68%
while deaths from breast cancer, prostate cancer, heart disease, stroke, and HIV decreased. AD
is already the most expensive condition in the nation costing $214 billion in 2014 and is
forecasted to cost $1.2 trillion in 2050.
AD belongs to a larger class of diseases known as protein conformational disorders
(PCDs). Other PCDs include Huntington disease, ALS, Parkinson disease and type II diabetes.
PCDs are caused by a change in the secondary and/or tertiary structure of protein without change
of the primary structure. Typically, PCDs cause a transformation from α- helices to β-sheets.
Misfolded proteins rich in β-sheets are termed amyloids, which are more specifically, tissue
deposits of rigid protein fibrils 5-10 nm in diameter. (2) In the native α- helix structure, the
hydrogen bonds are between groups within the same strand. Hydrogen bonds in the β-sheets are
between one strand and another. In most PCDs the misfolded protein becomes deposited in
amyloid-like aggregates inducing tissue damage and organ disfunction. (3)
AD is characterized by a few structural changes in the brain. First, neurons of the central
nervous system begin to die causing alterations in synaptic inputs. Additionally, cell bodies and
dendrites of these neurons contain neurofibrillary tangles (NFT) and the brain contains
extracellular deposits of amyloid-beta (Aβ). (4) The memory loss seen in patients with AD is due
to neuronal loss in regions related to memory and cognition, neurotransmitter depletion, and
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synaptic alteration. (5) The cause of this neuronal loss could be due to one or many of the
structural abnormalities seen in AD brains post mortem. The presence of Aβ plaques and
intracellular NFT containing phosphorylated tau has been of most interest in the determining the
causes of these changes. (6) The exact method in which Aβ, NFT and/or phosphorylated tau
cause neuronal death is unclear. (4) Cloning of the gene that codes for Aβ and its location on
chromosome 21, as well as the fact that Down Syndrome invariably leads to AD, led researchers
to pursue the hypothesis that Aβ accumulation is the key event in AD etiology. (7) This
knowledge supports the amyloid hypothesis, which suggests that the accumulation of Aβ in the
brain is the driving force behind AD pathogenesis and formation of NFT is a result of the
imbalance between Aβ production and Aβ clearance. The amyloid cascade hypothesis proposes
the sequence of events resulting in AD is as follows: mutations in amyloid precursor protein
(APP), presinilin (PS) 1, or PS2 genes, increased Aβ1-42 production, Aβ1-42 oligomerization and
plaque formation, subtle effects of Aβ1-42 oligomers on synapses, microglial and astrocytic
activation, progressive synaptic and neuronal injury, altered neuronal homeostasis, altered kinase
and phosphatase activity, widespread neuronal disfunction and cell death, dementia. (7)
Specifically, Aβ is a normal product of cleavage from APP. (5) Aβ can be measured in
cerebrospinal fluid, plasma, and culture medium. (7) APP is a naturally occurring 695-770 amino
acid peptide that is encoded on chromosome 21. (5) The function of APP in the nervous system
is unknown. Some studies have reported that APP has a role in signal transduction pathways and
the growth of neuronal and non-neuronal cells. (4) Typically, APP predominately follows a nonamyloidogenic pathway where it is cleaved by α-secretase, which does not result in the formation
of Aβ. (5) Conversely, when APP follows the amyloidogenic pathway, it is first cleaved by βsecretase creating a 99 amino acid peptide. The intermediate peptide is subsequently cleaved by
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ϒ-secretase creating Aβ. Depending on the point of cleavage by ϒ-secretase, Aβ monomer of
38, 40, or 42 amino acids is produced. (8) The 42 amino acid monomer is 4.5 kDa and has the
following sequence:
DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA
Figure 1: Amyloid-beta 1-42 amino acid sequence (6)

Aβ1-40, is the most abundantly produced isoform, but Aβ1-42 is more likely to oligomerize
and form amyloid fibrils in the brain parenchyma. (8, 9) Additionally, mutations in PS proteins,
specifically PS1 and PS2, have a direct effect on ϒ-secretase altering APP metabolism to
produce amyloidogenic Aβ. (7) Even though Aβ production is a naturally occurring process, the
overproduction of Aβ or increased proportion of Aβ1-42 has been shown to cause early onset AD.
(7)
The amyloid hypothesis provides a framework for the cascade of Aβ causing AD, but the
detailed process has yet to be discovered and agreed upon. The biggest criticism of the amyloid
hypothesis is the amount of insoluble Aβ plaques found in the brain post-mortem does not
correlate with the severity of symptoms the patient experiences during life. The amyloid
hypothesis is also lacking in detail because a specific neurotoxic species of Aβ or its effect on
neurons has not been clearly defined in vivo. (7) Research has supported the idea that a possible
precursor, soluble Aβ oligomers, is the primary toxic species as it appears to correlate with
cognitive impairment. To form fibrils and plaques, Aβ must accumulate, but the aggregation
pathway Aβ monomer follows to form Aβ oligomer and Aβ fibril has been difficult to elucidate
due to the metastable nature of the Aβ protein aggregates. Even though Aβ oligomers are kinetic
intermediates for fibril formation, it has been suggested they are not necessary intermediates for
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fibril formation. (10) Since oligomer formation is a dynamic process, it is likely that many
different species exist simultaneously, making neurotoxicity difficult to pin on one form. (7)
Additionally, all AD-causing mutations in APP, PS1, or PS2 increase Aβ deposition, but there is
no correlation with when AD symptoms begin to occur. (7) Neuronal death is present only in the
advanced form of AD and is hypothesized to evolve only after decades of damage. It is
suggested that Aβ toxicity is subtle until damage associated with oligomer stress and
accumulation occurs which causes the irreversibility of neurodegeneration. (6) Overall, there are
large gaps in the amyloid hypothesis for understanding the pathogenesis of AD. However, none
of the criticisms of the amyloid hypothesis are large enough to discount the theory and simply
relay the lack of understanding surrounding AD.
Indeed, even though the amount of insoluble Aβ does not correlate with AD symptoms,
many studies have supported that a soluble oligomer is the toxic species. (11) Research suggests
memory impairment occurs early and is attributed to nerve cell death. (9) Synthetic Aβ, termed
AD diffusible ligands (ADDLs), intermediates and fibrils cause minor injury to cultured neurons.
(7) Soluble, Aβ oligomers are shown to inhibit synaptic function by consistent aberrant signaling
leading to early memory deficits and synaptic degradation. (12) Campioni et al. determined that
when oligomers are produced intracellularly, flexible hydrophobic surfaces of Aβ are exposed
that might contribute to trapping vital proteins. When Aβ oligomers are produced
extracellularly, they cause toxic alterations of cell membranes. (13) Likewise, transgenic mice
studies have shown memory impairment and changes in neuron form before fibrillar Aβ is
deposited. (8) In vivo rat studies indicate that human Aβ oligomers can inhibit long-term
potentiation in the hippocampus, which is necessary for memory formation. This determination
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was made without the presence of Aβ monomers or fibrils, confirming that oligomers are the
toxic Aβ species. (7)
Extractions of AD brain tissue contain a large amount of soluble Aβ between 10-100
kDa, the majority of which existed in the dodecameric form. (12) In studies on AD brains, the
soluble Aβ level in the frontal cortex was increased three fold compared to non-AD controls and
there was no correlation in the amount of soluble and insoluble Aβ. (14) In contrast, Kasai et al.
reported lower levels of soluble Aβ in cerebrospinal fluid of AD patients. (15) The decrease of
Aβ in CSF is thought to be due to the deposition of Aβ in plaques and limiting its ability to
diffuse into CSF. (16) Walsh et al. showed that nonamer and decamer levels correlated with
spatial memory impairment when compared to monomer, trimer, and hexamer. However,
nonamer and decamers were not shown to correlate with other types of memory loss or synaptic
function loss. (8) It is possible that smaller order oligomers are the cause of other types of
memory impairment. Neurons in the medial temporal lobe and hippocampus are particularly
susceptible to loss in AD and their loss seems to coincide with cognitive impairment. (16)
Overall, experiments support the existence of soluble Aβ oligomers, but their direct effect on
neuronal toxicity has yet to be determined. (6)
The Aβ aggregation pathway to form these toxic oligomers and insoluble fragments
found in AD brains is largely unclear. The starting point is a native and active conformation
consisting of α-helical and random structure and the ending point is the same protein in a pleated
β-sheet conformation, typical of PCDs. (3) There are two known regions of Aβ that play a role in
aggregation and formation of fibrils. The C-terminal end plays a role in the rate of aggregation.
Therefore, Aβ1-42 aggregates much faster than Aβ1-40, as mentioned earlier. Additionally,
hydrophobic residues 16-23 are essential in peptide misfolding and the polymerization of Aβ. (5)
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Studies in human, transgenic mice, and cell culture show that soluble and insoluble Aβ exist in
equilibrium. (14)
It should be noted that terminology of Aβ structures is widely varied in published studies.
Here, oligomers refer to the structure between monomer form and insoluble fibril form. It
should also be noted that slight changes in Aβ concentration and preparation can lead to
differences in resulting Aβ distribution and therefore experimental results. There is no method
that prepares oligomeric Aβ in a physiological condition because the low nanomolar levels in the
brain are much lower than the micromolar levels needed for in vitro studies. (12) The low
concentration of Aβ oligomers and potent neurotoxicity make them a viable therapeutic target. It
is vital to understand this pathway in order to understand AD etiology and design a potential
drug to block the toxic effects of Aβ.

Capillary Electrophoresis
Capillary electrophoresis (CE) is an efficient and inexpensive way to separate protein
species based on their size and charge. CE creates a voltage between two buffer vials, which
induces a current to pull the protein through a capillary. The smaller, higher charged species
elute first and the larger, lower charged species elute last. The species are detected, in this case,
via UV absorption at 214 nm. CE cannot give specific information about the molecular weight
of the species, only the proteins relative size to charge ratio to other species in the sample.
Previous studies have shown CE is capable of monitoring Aβ aggregation. (17) However,
CE requires a micromolar concentration of Aβ rather than the physiological low nanomolar to
picomolar concentrations. Additionally, Aβ is a hydrophobic protein and can stick to the
negatively charged walls of the capillary rendering a false representation of the sample injected.
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Coating the capillary with a hydrophilic polymer will reduce the loss of Aβ, increase the ability
to see more of the aggregated species, and reduce the potential for Aβ to become unattached
from the capillary wall and ruin subsequent capillary runs. Ultimately, reducing the loss is
essential for Aβ detection at a physiological concentration
Polyethylene oxide (PEO) and poly-N-hydroxyethylacrylamide (PHEA) are dynamic
coating polymers that form an adsorptive layer on the capillary and show minimal protein
adsorption as well as suppression of electroosmotic flow (EOF). (18) Polyvinyl alcohol (PVA) is
a covalent coating that becomes chemically bonded to the capillary wall after a heat treatment
and has also been shown to decrease protein adsorption. (19) Determining an appropriate
capillary coating for CE that increases the amount of protein recovered will allow for a
physiological sample of Aβ to be studied. This coating can be translated to the development of a
microchip electrophoresis (ME) system that has the ability to detect metastable Aβ species at a
physiological, nanomolar scale. Ultimately, the ME system could lead to a commercially
available system to enhance AD studies worldwide.

Photo-Induced Cross Linking of Unmodified Proteins (PICUP)
Due to the metastable nature of Aβ, aggregation states have been difficult to elucidate, as
discussed previously. Photo-Induced Cross Linking of Unmodified Proteins (PICUP) is a method
with promising ability to stabilize Aβ at a specific time point and allow the aggregation pathway
to be studied. (20) PICUP utilizes photoexcitation of a ruthenium compound in the presence of
an electron acceptor creating a virtual snapshot of the protein structure at the time Aβ is exposed
to a brief flash of light. Ultimately, PICUP has the ability to cross-link Aβ in its native state (that
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is without the addition of chemical crosslinking agents). PICUP provides the crucial ability to
study Aβ in a fixed conformation, non-metastable state along the aggregation pathway.
Typically, after PICUP is performed on Aβ, the samples are run on an SDS-gel and the
molecular weights of Aβ at different aggregation time points are determined. However, the
SDS-gel denatures the protein and removes the secondary and tertiary structure. If PICUP
samples were analyzed via CE, the secondary and tertiary structure would remain intact.
Correlating a SDS-gel with CE could give more information about the specific sizes of species
present, their charges, and their amounts.

Purpose
Chapter 2 summarizes a study performed using CE that tested the coating abilities of
different hydrophilic polymers in order to minimize Aβ loss in capillaries. Capillaries were
dynamically coated with PHEA and PEO, which previously have shown the ability to lower Aβ
adsorption. Polyvinyl alcohol was also studied as a covalent coating. In this study, a protein
recovery of 90% was considered desirable. Minimal loss of Aβ is essential to be able to detect
Aβ at a physiological concentration and ultimately develop a microchip electrophoresis system
for commercial use.
Chapter 3 summarizes the use of PICUP to capture Aβ1-42 transient species on an SDSgel. It also discusses the novel ability to detect PICUP samples using CE and compare the
results with traditional SDS gels. CE could provide a higher resolution and non-denaturing
analysis of Aβ1-42 species . Correlating SDS-gel and CE will give insight into size of the species
present and development of a model to predict the molecular weight of Aβ1-42 species along the
aggregation pathway.
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Chapter 2: Minimizing Protein Loss
Introduction
Capillary electrophoresis (CE) is an efficient way to separate protein species based on
their size and charge, known collectively as electrophoretic mobility. Polyacrylamide gel
electrophoresis (PAGE) has been the predominate technique to separate protein species based on
their size. However, CE has many advantages over PAGE such as: shorter analysis times, easier
automation, and lower usage of chemicals. Additionally, CE allows for analysis of proteins in
their native state where the SDS in PAGE analysis denatures the protein and can remove the
secondary, tertiary, and quaternary structure.
Capillary electrophoresis begins by injecting a protein sample into a capillary. The
capillary is then filled with buffer and both ends are placed into buffer vials. A voltage is
applied between the buffer vials and current is induced to initiate protein migration from the
anode to the cathode, meaning positive ions elute first followed by neutral species then anions.
The protein species separate and are detected by UV absorption at 214 nm using a Deuterium
lamp. The output of the detector is an electropherogram showing protein absorbance as a
function of time.
The electrophoretic mobility (µ) of the protein species can be approximated by the
Debye-Huckel-Henry theory:
!

μ = !πη!

(1)

where q is the charge of the species, η is the viscosity of the buffer, and r is the Stokes’ radius of
the species. (21) A closer look at this equation shows a highly charged, small particle will have a
high mobility and elute first and a lower charged, large particle will elute last. Considering all
ions pass the detector, there must be a force sweeping anions towards the cathode since they
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should naturally repel. This force is called electroosmotic flow (EOF) and propels all ions
regardless of charge towards the cathode.
The EOF is caused by interactions between the buffer and the glass wall of the capillary
and results in low separation efficiency, which is the largest disadvantage to CE analysis. Low
resolution of the separation can also be caused by hydrophobic and electrostatic interactions
between the protein and wall of the capillary. (22) In more detail, fused silica capillaries have a
negative charge due to the ionization of silanol groups when in solution. When the capillary is
filled with buffer, the cations of the buffer are drawn towards the silanol groups and form a
double layer of cations. When a voltage is applied between the anode and the cathode, the first
layer is held tightly by electrostatic interactions and the second layer is drawn towards the
cathode. The flow of the second layer of cations is referred to as the EOF and causes the bulk
flow of ions towards the cathode. Assuming the EOF is larger than the electrophoretic mobility
of the protein, all protein species will be drawn towards the detector. When the value of the EOF
greatly dominates the protein’s electrophoretic mobility, a high protein resolution is difficult to
achieve. (23) Manipulation of the EOF is crucial to a fast and efficient protein separation.
Due to the negative charge of the capillary’s silanol groups and the positively charged
layer supplied by the buffer, protein species can adsorb to the walls of the capillary resulting in
protein loss. Typically, protein adsorbs to the capillary via electrostatic interaction, but hydrogen
bonding and hydrophobic interactions with already adsorbed protein can also occur. (24)
In order to overcome low separation efficiency, protein adsorption is slowed and the EOF
is suppressed by modifying the inside surface of the fused silica capillary. An attractive way to
modify the capillary surface is to add polymeric coatings that compete with the protein for
interaction with the silanol groups on the capillary wall. The availability of the protein to adsorb
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to the capillary wall is minimized because it now has a neutral charge. The EOF is suppressed
by the polymer coating increasing the solution viscosity in the first layer of ions without
affecting the viscosity of the second layer. It is essential that a highly acidic treatment is
performed prior to polymeric treatment to increase the silanol group availability for hydrogen
bonding with the polymer. (22)
The suppression of EOF and minimization of protein loss is essential to detect protein
present in low concentrations, such as the physiological nanomolar range of Aβ1-42. The
suppression of EOF can be measured by comparing the electrophoretic mobility of a protein in a
coated versus uncoated capillary. The adsorption of protein to capillary walls is measured by
comparing the area under peaks of the electropherogram after injecting the protein at the inlet
and outlet of the capillary. When the protein is injected at the inlet of the capillary, the protein
travels 21 cm from the anode to the detector. When the protein is injected at the outlet of the
capillary, the voltage is reversed and the protein travels 10 cm from the anode to the detector.
(See Figure 2 as a reference.)
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Figure 2: This is a schematic of capillary electrophoresis. When the sample is injected on the
long side, it travels from the source vial to the destination vial. When the sample is injected on
the short side, the cathode and anode are switched. Then, the sample is injected in the
destination vial and travels to the source vial. (25)

The differences in the length of capillary allows for different amounts of protein to be
adsorbed onto the capillary wall. Bohoyo et al. provide equation 2 to calculate the recovery
percentage of the protein.
𝑋 = 100 ∗ (𝐴! 𝐴! )!

(2)

where AL and AS are the peak area in the long and short capillary lengths, respectively. (26) A
protein recovery of 90% is considered desirable in this study. This assumes a representative
sample is injected on both the long and short runs.
Two approaches to surface modifications are dynamic and covalent hydrophilic polymer
coatings. Dynamic capillary coatings suppress the negative charge of the capillary wall by
electrostatic interactions with the capillary’s negatively charged silanol groups and covalent
coatings permanently suppress the negative charge by covalently bonding to the fused silica.
Typically, dynamic coatings are preferred to covalent coatings due to their simplicity and speed
of the protocol. However, covalent coatings are permanent and better suited for long studies. It
is important to optimize the adsorption properties of the polymer and the thickness of the coating
layer to achieve proper protein separation. The hydrophilic-hydrophobic balance of the polymer,
the polymer’s potential for hydrogen bonding with the capillary wall, and the nature of the
solvent should also be considered when choosing a polymeric coating. An ideal coating would
balance the ease of a dynamic coating with the longevity of a covalent coating. (22)
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EOF suppression and protein recovery calculations were performed to evaluate the
effectiveness of each coating. The dynamic hydrophilic polymers used in this study were polyn-hydroxyethylacrylamide (PHEA) and polyethylene oxide (PEO), both uncharged coatings.
PHEA has a high hydrophilicity and has been shown to be favorable for suppression of protein
adsorption. (27)
PEO can form a dynamic coating due to its ability to hydrogen bond with the silanol
groups along the capillary wall. A dynamic PEO coating has been shown to be more effective
than a covalent PEO coating at suppressing the EOF. (27) Therefore, only a dynamic PEO
coating was used in this study.
The covalent coating tested in this study is polyvinyl alcohol (PVA), as it is considered to
be the most hydrophilic polymer. (28) Steiner et al. showed PVA was the most efficient in EOF
control in aqueous systems when compared to vinyl, vinyl acetate, and acrylates. (23) A
covalently coated PVA capillary has been shown to have superior separation of basic proteins
over a wide pH range and last for over 1000 runs. (28) The capillary must be acidified with
glutaraldehyde as a cross-linking agent prior to PVA treatment. The coating occurs at the
interface between the glutaraldehyde and PVA solutions, creating a uniform layer along the
capillary wall. (27) It is necessary to treat the capillary with heat up to 160°C so the poly vinyl
alcohol becomes water insoluble. At temperatures higher than 160°C, the polymer starts to
degrade. (19) Since PVA coating procedure is performed by hand versus by the CE machine, it is
prone to human error. Additionally, PVA is first adsorbed onto the capillary wall before thermal
treatment, the coating procedure itself is prone to inconsistencies. (27) The potential for
inconsistent coating errors should be taken into account when performing the procedure and
analysis.
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Determining the best polymeric capillary coating is essential to reducing the loss of
protein via capillary wall attachment and therefore accurately detecting Aβ1-42 aggregates. The
purpose of this study is to determine a coating that effectively reduces EOF and provides at high
recovery of Aβ1-42. Ultimately, this knowledge will be applied to the development of a
microchip electrophoresis system, which has the ability to detect Aβ1-42 in its physiological
nanomolar concentration.

Materials and Methods
Amyloid beta preparation
Amyloid beta (Anaspec, Freemont CA, Lot #1360300 and 1472260), was stored at 80°C. To ensure samples were monomeric a 1 mg/mL stock of amyloid beta was prepared in
Hexofluoro-2-propanol (HFIP). Amyloid beta was aliquotted into vials containing 0.0271 mg
and the HFIP was allowed to evaporate in the hood overnight. The amyloid beta was brought up
to a concentration of 20 µM with 10 mM phosphate buffer.

Capillary Electrophoresis
Capillary electrophoresis was performed using a Beckman P/ACE MDQ (214 nm filter).
The machine was interfaced with an IBM computer and Beckman Coulter 32.0 Karat software
(Version 5.0). Samples were pressure injected for 35 seconds at 0.5 psi. Long runs were
separated at 7 kV for 60 minutes and short runs were separated at 7 kV for 30 minutes in a 31 cm
fused silica capillary of 50 µm diameter. Long and short runs were alternated with a capillary
rinse in between to wash out any residual protein not detected. The capillary rinse consisted of
deionized water wash for 10 minutes at 50 psi then 100 mM phosphate buffer wash for 10
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minutes at 50 psi. Long and short runs were examined in triplicate resulting in six runs per
capillary. Each coating was tested on two capillaries.
The dynamic coating process was initiated by a preconditioning rinse in the CE machine.
The preconditioning rinse consisted of: 20 minutes at 50 psi with 0.1M NaOH, 20 minutes at 20
psi with deionized water, and 60 minutes at 20 psi with 0.1M HCl. The coating step started with
a 15 minute deionized water wash at 20 psi, then a 15 minute 0.1M HCl rinse at 20 psi. The
capillary was then rinsed with the coating of choice for 30 minutes at 50 psi. Next the capillary
was rinsed for 15 minutes at 20 psi with deionized water. The capillary then was rinsed for 10
minutes with deionized water followed by a 10 minute polymer rinse.
The covalent coating process was developed in house based on work by Belder et al. (28)
A custom built device to coat the capillary was influenced by one described by Buchholz et al.
(29) A nitrogen gas port was attached on the outside of the device leading into a chamber filled
with polymer solution, as seen in Figure 3. The capillary was inserted into the chamber and
sealed airtight. When nitrogen was applied to the system, the solution was forced through the
capillary. The 0.5% PVA procedure slightly modified from Belder is as following: push aqueous
glutaraldehyde solution through capillary with 100 psi of N2 for 30 minutes, purge the capillary
with N2 at 100 psi for 10 minutes, push an acidified PVA solution through the capillary with 100
psi of N2 for 30 minutes, purge the capillary with N2 at 100 psi for 10 minutes. Afterwards, the
capillary was put in an oven and heated from 25°C to 160°C for over 20 minutes.
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Capillary insertion
Screw cap

Nitrogen port

Sample chamber

Figure 3: The device created in house to coat capillaries with .5% PVA is shown above. The
nitrogen attachment is located on the left. The capillary is inserted through a rubber stopper at
the top into the bottom chamber containing the coating solution. The attachment at the top can
then be turned to create an airtight seal. The entire device is turned horizontally when coating so
gravity is not acting against the direction of flow.

Data Analysis
Capillary electrophoresis data was analyzed using Origin 9.0 and Microsoft Excel. The
data was imported into Origin, where the noise baseline was subtracted from the data set to
produce a constant baseline of zero. This data was copied into excel where it was plotted versus
time. In Origin, the peak was fitted to a bigaussian curve because this curve had the best fit to
the peaks. The peak elution time, height, and area under the curve were recorded as well as the
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noise of the data. The area was compared between long and short runs to calculate the recovery
using equation 2. All long runs were plotted with a non-zero baseline to make the comparable
peaks easier to visualize. The signal to noise ratio was calculated by taking the average of the
signal from the start of the peak to the end of the peak and dividing it by the average of the
baseline signal.

Results and Discussion
The effect of capillary coating on protein adsorption was investigated. Peak height had to
be at least three times the noise of the data to be considered acceptable signal. For short runs,
the protein traveled 10 cm to the detector, and protein separation occurred for 30 minutes. For
long runs, the protein traveled 21 cm to the detector, and protein separation occurred for 60
minutes. Most of the electropherograms were adjusted so only the first 15 minutes of data are
shown.
Control
The control condition was an uncoated capillary and therefore no suppression of the EOF.
Figure 4 shows a representative electropherogram for a long and short run of unaggregated Aβ142.
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Figure 4: A representative electropherogram of Aβ1-42 on an uncoated capillary for lot #1360300
and an 8 second injection time. The short run analyzed the peak eluted around 5 minutes. The
long run analyzed the peak eluted around 9 minutes.

Theoretically, the peak being examined is a monomer peak, however, due to the
metastable nature of Aβ1-42, the exact size of the species is unknown. Lot #1360300 was tested
first. The peaks being compared are detected around 5 minutes and 9 minutes for the short and
long runs, respectively, as shown in Figure 4. The average recovery of these peaks was 67.5%
with a standard deviation of 4.98% (n = 3). The significant discrepancy between observed peak
recovery and ideal peak recovery show the importance of controlling the EOF and minimizing
protein loss. In order confirm the results, an additional distinct capillary needed to be tested, but
a different lot of Aβ1-42 had to be used. Figures 5,6, 7, and 8 show Aβ1-42 from lot #1472260.
This lot displayed vastly different results from lot #1360300. First, Aβ1-42 was not detected at the
same concentration, 20 µM, for an 8 second injection time. After copious amounts of testing to
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be able to detect Aβ1-42, the concentration was increased to 40 µM and injection time was
increased to 35 seconds. Secondly, the two peaks compared were about 1.7 minutes and 3.5
minutes for the short and long runs, respectively. This peak elution is much shorter than the
previous lot of Aβ1-42. Similarly, long and short runs were alternated for a total of six runs. The
first two runs had an Aβ1-42 recovery of 66%. However, when the next long and short runs were
analyzed and compared, it was found that the recovery was greater than 100%. Theoretically,
this is not possible which indicates an error in the experiment.
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Figure 5: The first long run and short run electropherogram for an uncoated capillary where Aβ142 was

injected for 35 seconds. The short run analyzed the peak eluted around 1.7 minutes. The

long run analyzed the peak eluted around 3.5 minutes.
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Figure 6: The second long run and short run electropherogram for an uncoated capillary where
Aβ1-42 was injected for 35 seconds. The short run analyzed the peak eluted around 1.7 minutes.
The long run analyzed the peak eluted around 3.5 minutes.

Table 1: The area and recoveries for the first two sets of uncoated capillary runs (Figures 4 and
5) where Aβ1-42 was injected for 35 seconds.
Short #1
Long #1
Short #2
Long #2

Time
Area
Fit
1.70
1.38E-04
3.45
1.12E-04
1.67
1.03E-04
3.15
2.29E-04

0.792
0.442
0.714
0.779

Recovery
66.0
489

The first recovery of 66% for an uncoated capillary was expected. However, the second
recovery of over 100% was not. As you can see the area for long run #2 is about twice as much
as the area for long run #1. The peaks were fit to a bigaussian curve and since the noise for
uncoated capillary data was large, the fit was not ideal. However, long #1 had a particularly bad
fit. Additionally, the peaks were not as sharp as expected and had a somewhat flat top. In order
to increase the fit, the injection time of Aβ1-42 was decreased to 25 seconds. These results are
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displayed in Figures 7 and 8 and Table 2.
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Figure 7: The first long run and short run electropherogram for an uncoated capillary where Aβ142 (lot

#1462260) was injected for 25 seconds. The short run analyzed the peak eluted around 1.7

minutes. The long run analyzed the peak eluted around 3.5 minutes.
30uM, 25s Injection #2
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Figure 8: The second long run and short run electropherogram for an uncoated capillary where
Aβ1-42 (lot #1462260) was injected for 25 seconds. The short run analyzed the peak eluted
around 1.7 minutes. The long run analyzed the peak eluted around 3.5 minutes.
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Table 2: The area and recoveries for the first two sets of uncoated capillary runs (Figures 6 and
7) where Aβ1-42 was injected for 25 seconds.
Short #1
Long #1
Short #2
Long #2

Time
Area
Fit
1.61
6.87E-05 0.700
3.39
5.71E-05 0.251
1.70
6.84E-05 0.943
3.42
8.39E-05 0.640

Recovery
69.2
150

Interestingly, even though the peaks are more bell shaped and therefore more apt to fit a
bigaussian curve, the data did not reflect it. The fit was still low. This suggests that the large
noise present in the data is at fault for the insufficient fit of the peaks. It is also interesting that
the second set of short and long runs had a recovery greater than 100%, similar to the runs where
Aβ1-42 was injected for 35 seconds. It is possible that Aβ1-42 from a previous run is eluting during
a later run and therefore creating a falsely high recovery. Additional experiments were performed
lengthening the run time up to 60 minutes, but the results were the same. (Data not shown).
More experiments should be performed to lengthen the rinse time between runs to see if this
affects the recovery of Aβ1-42.

12500 kDa PHEA
Only lot #1360300 was tested with 12500 kDa PHEA as a coating. Figure 9 shows
representative runs when a capillary is coated with 12500 kDa PHEA. The Aβ1-42 peak time
elution and area were inconsistent when the capillary was coated with PHEA. The two peaks
compared are the short peak around 5 minutes and the long peak around 10 minutes. The
average recovery was 297% with a standard deviation of 262%. All runs except 1 resulted in
protein recovery greater than 100%, which is impossible. There were 3 groups of long and short
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runs able to provide a recovery. While more testing was done, some runs did not detect any Aβ142 providing

no peaks for comparison or analysis. This polymer has a very high molecular

weight which makes it more viscous than lower molecular weight polymers. Therefore it is
likely that the polymer was not able to completely coat the capillary. Additionally, PHEA itself
absorbs UV light at 214 nm which could lead to unrealistic recovery values or inconsistent
results. Therefore, PHEA is not an acceptable polymeric coating for the purposes here.
12500kDa PHEA
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Figure 9: Representative electropherogram for a capillary coated with 12500 kDa PEO for lot
#1360300 of Aβ1-42. The peaks analyzed occurred at 5 minutes and 10 minutes for the short and
long runs, respectively.

PEO
Multiple molecular weights of PEO were available to test for capillary coating.
Generally, the higher molecular weights served as better coating polymers due to their higher
viscosity. However, if the viscosity was too high, an uneven coating was accomplished resulting
in poor recovery of Aβ1-42. Additionally, since Aβ1-42 is a small protein, a small molecular weight
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PEO was tested to study the range of PEO. Only lot #1360300 of protein was tested for PEO
coated capillaries since lot #1462260 was not providing adequate results on the simpler uncoated
capillary.

50 kDa PEO
The smallest molecular weight of PEO tested was 50 kDa. The elution of peaks was
inconsistent, making the ability to calculate recovery impossible.

Only one set of runs eluted a

peak on both the long and short version, these runs are shown in Figure 10. This set had a protein
recovery of 46%. Only one long run had a peak detected, suggesting that all of the protein
adsorbed to the walls of the capillary. The short runs had a large variation of peak elution time
with the average being 13.1 minutes ± 2.17 minutes. The inconsistent detection of peaks is not
desirable for a polymeric coating. Since only one set of runs was capable of analysis, 50 kDa
PEO is not suggested as a polymeric coating.
50kDa PEO
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Figure 10: A representative long run and short run electropherogram for a capillary coated with
50 kDa PEO. Only one long run showed a peak, which eluted around 4 minutes. The short run
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had a large variation of peak elution time.

2000 kDa PEO
The next molecular weight tested was 2000 kDa PEO. It was the best dynamic coating
with a peak recovery of 87.4% and a standard deviation of 4.8%. The two peaks compared were
the short run around 5 minutes and the long run around 10 minutes. Figure 11 shows the
representative electropherograms for a capillary coated with 2000 kDa PEO. The peaks
compared occurred at 5 minutes and 10 minutes for the short and long runs, respectively. Even
though the average peak recovery is slightly less than the 90% ideal recovery, 2000 kDa PEO
still showed the most promise as a coating. Out of this study, 2000 kDa PEO had the best
protein recovery and performed better than an uncoated capillary. However, only three short and
long run comparisons were able to be performed. Lot #1360300 of Aβ1-42 was not available for
more experiments and lot #1462260 was showing vastly different results as shown in the
uncoated capillary section.
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Figure 11: A representative long and short run electropherogram for a capillary coated with 2000
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kDa PEO. The peaks compared occurred around 5 minutes and 10 minutes for the short and long
runs, respectively.

5000 kDa PEO
Previously, the noise background was subtracted from the data for a constant baseline of
zero. This was not performed with 5000 kDa PEO coated capillaries due to a peak abnormality.
The peak abnormality made the peak area calculation user dependent because the peak beginning
and end were not an obvious deviation from the background. The peak recovery was not
calculated for any run where 5000 kDa PEO was used as the coating polymer due to the possible
inconsistency of user analysis. However, there was consistent activity detected around 3 and 5
minutes for short and long runs, respectively, as shown in Figure 12. Therefore, 5000 kDa PEO
is not suggested as a polymer coating due to the atypical peak shape and significant user bias
during analysis.
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Figure 12: Representative electropherograms for a capillary coated with 5000 kDa PEO are
shown. Typical bell shaped peaks did not occur, but every run had activity occurring around 3
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minutes and 5 minutes for short and long runs, respectively.

8000 kDa PEO
The representative electropherograms for a capillary coated with 8000 kDa PEO are
shown in Figure 13. The peak recovery was largely askew for capillaries coated with 8000 kDa
PEO. If the short runs detected a peak, it was around 5 and the long runs detected a large peak
occurring around 10 minutes. Only two groups of long and short runs were possible due to the
short runs not detecting Aβ1-42. The average recovery was 1.4E5% with a standard deviation of
1.9E5%. This recovery is much larger than expected and results were largely varied. The
extreme difference in peak areas could be due to the highly viscous nature of 8000 kDa PEO.
Due to the viscosity, it is possible that the capillary was coated unevenly creating extreme error
in the results. Furthermore, the short end of the capillary could have been coated very thickly
and the long end of the capillary not coated at all. There is also a possibility that the PEO
created a plug in the capillary and this contributed to the vastly different peak areas dependent on
the run direction. Since the short end of the capillary was likely thickly coated, the protein had a
much more difficult time navigating through the capillary to the detector, resulting in no
detection. The long runs showed multiple peaks due to the fact that the farther end was hardly
coated and the large peak was likely due to protein build up near the detector.
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Figure 13: Representative electropherograms for a capillary coated with 8000 kDa PEO. The
long runs showed a large peak starting around 10 minutes with a long tail. If the short runs
detected a peak it was around 5 minutes.

0.5% PVA
Polyvinyl alcohol was the only polymeric covalent coating analyzed. The exact
molecular weight of PVA used to coat was difficult to determine since the coating process is
more involved and the reaction occurs inside the capillary. Figure 14 shows representative
electropherograms for the capillaries coated with 0.5% PVA. The two peaks compared were the
short run around 25 minutes and the long run around 45 minutes. The peak recovery varied
between the two capillaries tested. The average peak recovery for the first capillary was 64.3%
+/- 49.1%. The average recovery was actually worse than that of an uncoated capillary. The
second capillary had an average peak recovery of 1.8E4% with a standard deviation of 2.8E4%.
Again, realistically a peak recovery greater than 100% is not valid. Due to the recovery
inconsistency of Aβ1-42 when the capillary is coated with PVA, it was determined that PVA
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would not be an acceptable polymeric coating in this instance.
However, theoretically, covalently coated capillaries last longer than dynamically coated
capillaries. No experiments were performed to determine how many runs the 0.5% PVA coating
lasted, but this could be a possible future study. For consistency, this may make 0.5% PVA a
more attractive coating than 2000 kDa PEO since the protein recovery values are competitive.
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Figure 14: Representative electropherogram for a capillary coated with 0.5% PVA. The runs
analyzed occurred around 25 minutes and 45 minutes, for the short and long runs, respectively.

Overall Results
Overall, there is still a need to determine the best option for capillary coating to reduce
Aβ1-42 loss when analyzing by CE. Recovery of Aβ1-42 on an uncoated capillary is between 65%
and 70%. The best coating tested in this study was 2000 kDa with a recovery just under 90%,
the protein recovery goal. The biggest issue with this study is a prominent recovery greater than
100%. It is still not fully understood why this issue is occurring, but it persists no matter the
coating type. The most likely reasons for this issue are either a need for a better protein removal
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rinse or an issue with the instrument sample injection due to an old pressure pump. Additionally,
it should be pointed out that results vary depending upon the lot of Aβ1-42.
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Chapter 3: Photo-Induced Cross Linking of Unmodified Proteins
Introduction
Understanding how Aβ1-42 influences the degradation of neuronal cells requires
knowledge of its formation including kinetics and structure. Due to the constantly evolving
understanding of Aβ1-42 aggregation, it has been impossible to achieve a consensus among the
scientific community. Cross-linking proteins could be a useful tool to understand the
mechanisms in which proteins aggregate. However, current crosslinking methods have
significant drawbacks of long reaction times with low yields.(30) Additionally, these
crosslinking methods may require modifications of nucleophillic side chains and/or bifunctional
crosslinkers, which have the potential to produce artificial results. An efficient and chemically
inert method for crosslinking unmodified proteins, that occurs in less time than the protein takes
to alter conformation, would be necessary to study this kind of interaction. The Kodadek
laboratory at the University of Texas designed a light activated reaction capable of crosslinking
proteins without modifying the protein prior to application. (30) This method, termed photoinduced crosslinking of unmodified proteins (PICUP), is about 60% efficient with a 0.5 second
light exposure. PICUP was shown by Bitan et al. to efficiently and accurately capture transient
oligomer species of Aβ1-40 by comparing the captured oligomer distribution to the oligomer
distribution of native monomeric proteins and the distribution relationship to irradiation time.
(20) Applying PICUP to Aβ1-42 at a fixed time interval during aggregation could help determine
the size distribution and relative abundance of Aβ1-42 during the aggregation process.
PICUP is initiated by the light excitation of a tris(2,2’-bipyridyl)dichlororuthenium(II)
complex which has a maximum UV absorption at 452 nm. (30) When Ru( II) is exposed to a
short burst of light in the presence of an electron acceptor, such as ammonium persulfate (APS),
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Ru (II) is oxidized to Ru (III). Ru (III) abstracts an electron from a nearby protein molecule
regenerating Ru (II) and creating a protein radical. Ru (II) continues the cycle of protein radical
formation until a reducing agent is added. This reaction is represented in Figure 15. The protein
radical is free to attack a neighboring protein to form a covalent bond. Theoretically, the protein
radical can form anywhere along the peptide chain. However, the radical preferentially forms at
Tyr, His, or Met due to aromatic stabilization and neighboring group effects. (31) The primary
factor to determine how the peptide is crosslinked is how close the radical is to a potential
electron donor. The nature of the radical is unimportant because it will either be crosslinked or
quenched by a solvent. (32) The use of long wavelength light is preferable because few
molecules absorb outside the UV region, so PICUP could eventually be applied to living cells.
In the absence of APS, the photoexicted Ru(III) generates a singlet oxygen. This reaction is
about 20 fold less efficient and requires more light than PICUP with an electron acceptor. (30)
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Figure 15: PICUP reaction scheme is shown starting with ruthenium being exposed to light in the
presence of APS. A ruthenium(III) radical is then generated which extracts an electron from a
neighboring residue. Ruthenium (II) is regenerated which can restart the process. The protein
radical joins a neighboring protein residue and becomes cross-linked. The reactions is stopped
by adding a reducing agent such as DTT or β-mercaptoethanol. Reprinted with permission from
Bitan G, Teplow D. Rapid photochemical cross linking- a new tool for studies of metastable,
amyloidogenic protein assemblies. Accounts of Chemical Research. 2004;37(6):357-64.
Copyright 2015. American Chemical Society.

PICUP is essential to studying Aβ aggregation prior to SDS-PAGE analysis. Typically,
protein complexes dissociate when treated with SDS so observation of larger assemblies under
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native conditions cannot be detected via SDS analysis. Additionally, it has been demonstrated
that SDS can artificially induce oligomerization of Aβ and Aβ can form SDS-stable oligomers.
(11) Because Aβ is an amphipathic protein, the protein is divided into SDS micelles, which
causes a high concentration of monomer in the micelle and results in oligomerization. Therefore,
Aβ oligomer distributions shown via SDS-PAGE do not accurately reflect the native distribution.
(33) It is necessary to covalently cross-link the oligomers so they are stable in the presence of
SDS in order for this method to more accurately reflect the true aggregation species. (11)
PICUP samples have historically been analyzed by SDS-PAGE. However, SDS-PAGE
only gives information about the relative molecular weight of samples present. Additionally,
SDS denatures the protein as it travels down the gel and breaks down the protein’s secondary and
tertiary structure. A novel approach used in this study is to analyze PICUP samples using
capillary electrophoresis (CE). CE separates proteins based on their size and charge. However,
correlating individual peaks to a specific charge or size cannot be directly determined and
therefore would require a model of the system. CE also allows the protein to remain in its native
conformation as it is detected by UV light at 214 nm. By coupling SDS-PAGE and CE analysis,
the limitations of both methods are counteracted and a plethora of information can be gained
about the aggregation pathway of Aβ1-42.
Bitan et al. successfully applied PICUP and densiometrics with AB1-42 and found that
oligomers preferentially exist in pentamer/hexamer units rather than monomers. (34) The three
distinct groups of aggregate-free Aβ1-42 oligomers were found to be: monomer through trimer,
tetramer through octamer, and dodecamer through octadecamer. Monomer through trimer
showed decreasing intensity as higher order oligomers were formed. Tetramer through octamer
showed a Gaussian-like distribution with the maximum occurring at pentamer/hexamer. The
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intensity of the bands correlating to higher order oligomers seemed to form from self-association
with pentamer/hexamer units. (34) The Aβ1-42 assembly studied by Bitan et al consisted of
aggregate free samples. In this study, PICUP will be applied to Aβ1-42 samples at distinct time
points after inducing aggregation to deduce the size of Aβ1-42 species along the aggregation
pathway.
Ultimately, the experimental data correlating the molecular weight and electrophoretic
mobility via SDS-PAGE and CE, respectively, will be used as a basis for a computational model
that has the ability to more rapidly analyze the size and concentration of Aβ1-42 present in a
sample. The molecular weight determined by SDS-PAGE analysis shows roughly the size of the
species present, but not the exact molecular weight. Therefore, there is a need for a model that
can predict the molecular weight of the species present based on the electrophoretic mobility
provided by CE (or ME) analysis.
The electrophoretic mobility can be calculated by the following equation:
𝜇=

!! !!
!! !

(3)  

where Ld is the length of the capillary to the detector, Lt is the total length of the capillary, tm is
the migration time of the protein, and V is the applied voltage. The extended Ogston model
correlates the electrophoretic mobility in a sieving matrix to the electrophoretic mobility in
buffer solution by:
log 𝜇 = log 𝜇! − 𝐾! 𝜙

(4)

where µ is the sieving electrophoretic mobility, µo is the buffer electrophoretic mobility, KR is
the protein retardation coefficient, and Φ is the polymer concentration (weight percent). A
Ferguson plot (log (µ / µo ) vs. Φ) is used to determine the protein retardation coefficient, where
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the slope is negative KR. The protein retardation coefficient relates to the radius of the protein
by:
𝐾! = 𝜋𝑙 ! (𝑟 + 𝑅)! x10!!"

(5)

where l’ is the total length of the polymer fiber per unit volume, r is the polymer fiber radius, R
is the protein radius. Multiangle light scattering (MALS) can be used to determine the polymer
fiber radius and the protein radius. It can be assumed that the Aβ1-42 aggregate radius is an
effective radius since the aggregate may or may not be spherical. Once the radius is determined,
the molecular weight can be related to the radius by:
! !! ! ! !

𝑅! = (!

!"

)

! x10!

(6)

where RM is the effective radius, VM is the partial specific volume, Mw (Da) is the molecular
weight, and N is Avogadro’s number. The MATLAB code for this simulation can be viewed in
the Appendix.

Materials and Methods
Amyloid beta preparation
Amyloid beta 1-42 (Anaspec, Freemont CA, Lot #1360300), was stored at -80°C. To
ensure samples were monomeric, a 1 mg/mL stock of amyloid beta was prepared in Hexofluoro2-propanol (HFIP). Amyloid beta was aliquotted into vials containing 0.0271 mg and the HFIP
was allowed to evaporate in the hood overnight. The amyloid beta was brought up to an initial
concentration of 20 µM with 5 mM NaOH and 10 mM phosphate buffer.

PICUP
Photo-induced cross-linking of unmodified proteins was performed using a Carl Zeiss
Xenon arc lamp XBO 75W/2 with power supply model #910135, 120V/120W, 50W HBO/75W
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XBO. The camera used was a Mamiya/Sekor 500 DTL. The camera was interfaced with a 9.875
inch cardboard tube to ensure the camera remained a constant distance from the Xenon lamp.
Light exposure was controlled with a shutter setting of 1 second. No filter was used to filter the
light. The reaction was performed in a dark room. The protocol was developed based on Bitan
et al. with modifications as described below. (33) Bitan et al. successfully used a 1:2:40
Aβ:Ru:APS mol ratio and 1 second of light exposure to capture Aβ oligomeric species. In order
to capture Aβ oligomeric species in the Hestekin laboratory, a 1:500:10000 Aβ:Ru:APS mol
ratio and 1 second of light exposure was used.
Final concentration of .033mM Aβ1-42 was added to 0.5 mL non-stick eppendorf tubes
followed by 1.67 mM Ruthenium and 33.3 mM Ammonium Persulfate (APS), all dissolved in
10mM phosphate buffer. Once APS was added to the reaction mixture, the tube was quickly
placed in front of the camera lens, perpendicular to the beam of light, and exposed to 1 second of
light by pressing the camera shutter. The reaction was quickly quenched with 5% βmercaptoethanol and placed in the -80°C freezer. All PICUP samples analyzed via capillary
electrophoresis were done so on a capillary coated with 2000 kDa PEO. The sample was
electrokinetically injected for 15 s and separated at 7 kV for 30 minutes with a 0.17 min ramp.
No polymer matrix was used for separation. PICUP samples analyzed via SDS-PAGE were run
on a 12% Tris-glycine gel to analyze higher molecular weight species or on a 16.5% Tris-tricine
gel to analyze lower molecular weight species. Each gel was run for 2.5 hours at 100 V with 20
µL of sample per well. GE Healthcare Life Sciences PlusOne Protein Silver Staining Kit was
used to stain the SDS-PAGE gels.
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Figure 16: The photo-system used for performing PICUP on Aβ1-42. The eppendorf tube
containing the sample is placed in a small hole right in front of the camera. The amount of light
exposed to the sample is controlled by the shutter speed. The phototube keeps the sample 9.875
inches from the Xenon lamp. This is estimated to be about 75 Joules of light.

Data Analysis
Capillary electrophoresis data was analyzed using Origin 9.0 and Microsoft Excel. The
data was imported into Origin where the baseline was subtracted by user identification. The
peaks were fit with a bigaussian curve. The area under the bigaussian curve was calculated by
“Peak Analyzer” using the Origin software. The data was copied into excel where it was plotted
versus time. Gels were scanned with an Epson scanner at 600 dpi.

Results and Discussion
Bitan et al. successfully used a 1:2:40 Aβ:Ru:APS mol ratio and 1 second of light
exposure to capture Aβ oligomeric species.(33) After PICUP application, Aβ1-42 showed a ladder
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of bands ranging from molecular weight 4.2 kDa to 55.4 kDa via SDS-PAGE and silver staining
analysis. Without light irradiation, Aβ1-42 had two bands around 4 kDa and 14 kDa (monomer
and trimer). Bitan’s results are shown in Figure 17 and were used as the Hestekin’s lab standard
for success.

Figure 17: Example of the ladder-like distribution seen by Bitan et al. for Aβ with a different Cterminus after applying PICUP. The ladder-like distribution is what the Hestekin lab considered
to be a successful application of PICUP to Aβ. Reprinted with permission from Bitan and
Teplow (2004). Rapid photochemical cross linking- a new tool for studies of metastable,
amyloidogenic protein assemblies. Accounts of Chemical Research. 2004;37(6):357-64.
Copyright 2015. American Chemical Society
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The ratio used by Bitan et al. was repeatedly unsuccessful in the Hestekin laboratory. A
study was conducted to optimize the oligomeric Aβ1-42 capture by increasing the ratio of
reactants to Aβ1-42. Table 3 describes this study and the results are presented in Figure 18.

Table 3: Optimization of PICUP reaction for Aβ1-42 by varying the molar ratio of the reactants.
All values of reactants given are the final concentration in mM. The quench agent, βME, must
be added in 1:1 ratio to the amount of sample. Samples 1 and 2 are similar to the experiment
performed by Bitan et al.

Sample
1
2
3
4
5
6
7
8

	
  

Aβ1-42
(mM)
0.018
0.018
0.016
0.016
0.007
0.007
0.007
0.007

Ru(bpy)3
(mM)
0.050
0.050
0.091
0.091
0.333
0.333
3.333
3.333

APS
(mM)
1.000
1.000
1.818
1.818
6.667
6.667
66.667
66.667

Light
(sec)
0
1
0
1
0
1
0
1

Aβ:
Ru(bpy)3:
APS
1:2.78:55.6
1:2.78:55.6
1:5.56:111.1
1:5.56:111.1
1:50:1000
1:50:1000
1:500:10000
1:500:10000

40

25 kDa
20 kDa
15 kDa
10 kDa
5 kDa
2 kDa
Sample
Aβ
Ru
APS
Light

1
.02
.05
1.0
-

2
.02
.05
1.0
+

3
.02
.09
1.8
-

4
.02
.09
1.8
+

5
.01
.33
6.7
-

6
.01
.33
6.7
+

7
.01
3.3
67
-

8
.01
3.3
67
+

Figure 18: Results from the optimization of PICUP reaction. Samples 1 and 2 are of Bitan et al.
concentrations. Considering the reaction looks the same with and without light, protein capture
was not successful. However, increasing the reactants amounts 180-fold to Aβ produce the
appropriate results, as seen in sample 8. The final concentrations of each reactant are displayed
in Table 1.

Samples 1 and 2 are similar to the molar ratio used by Bitan et al. for Aβ1-40. Samples 3
and 4 double the reactant to Aβ1-42 ratio. Samples 5 and 6 contain almost an 18-fold increase in
the molar ratio of reactants to Aβ1-42. Samples 7 and 8 contain almost an 180 fold increase of
Ru(bpy)3 and APS to Aβ1-42. Figure 18 displays the ladder-like distribution of Aβ of varying
lengths after applying PICUP reported by Bitan et al.
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As seen in samples 1-4 of Figure 17, the molar ratio used by Bitan et al. and an excess of
that used by Bitan et al. were unsuccessful in capturing the oligomeric Aβ1-42 species as it does
not show the reported ladder like distribution. Additionally, the samples that were exposed to
light look identical to the samples that were not exposed to light, suggesting that irradiation by
light did not occur. Samples 5 and 6 contain an almost 18-fold increase in reactant ratio. Sample
5 was not exposed to light and looks identical to samples 1 through 4. However, when the same
sample (sample 6) is exposed to one second of light, additional bands are shown between 20 and
25 kDa. Increasing the ratio 10-fold more, sample 7 looks similar to samples 1 through 5 and
was not exposed to Xenon light. Sample 8 shows the ladder distribution of Aβ reported by Bitan
et al. and resulting in an effectively photo-crosslinked Aβ. A few ladder species are seen in
sample 7 when no Xenon light is applied to the sample. This is likely due to unavoidable
arbitrary light. Interestingly, for samples 1 through 5 where PICUP was not successful, three
bands were identified: one band between 2 and 5kDa and two bands between 10 kDa and 15
kDa. This directly correlates to Aβ samples taken from the temporal cortex of patients with AD
and detected via immunoprecipitation/western blotting. (6) The specific reported molecular
weight of these bands was 4.1 kDa, 7.5 kDa, and 12.1 kDa. This further confirms the need to use
PICUP to accurately visualize the Aβ species present in a sample.
After the appropriate molar ratio of reactants was determined, the validity of each
reaction component in the PICUP procedure was tested and analyzed on a 16.5% Tris-tricine gel
to observe that each reactant is needed for the reaction to proceed optimally. These results are
shown in Figure 19. Additionally, it was important to determine if the reaction would proceed
with minimal (or no) use of a reactant as the more reactants used, the higher the chances for
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interference with CE detection. All samples were quenched with 5% β-Mercaptoethanol at a 1:1
ratio to the sample amount. Each sample alternated no light and 1 second of light exposure.
Samples 1 and 2 contain no Aβ and therefore no protein bands. Samples 3 and 4 contain no
Ruthenium, and 3 strong bands around 3, 10, and 13 kDa. Samples 5 and 6 contain no APS.
Sample 5 has the same bands as the samples containing no Ruthenium. Sample 6, however,
shows a ladder of bands. This supports the claim that Ruthenium generates a singlet oxygen in
the absence of APS and the presence of light due to the fact that the ladder of bands are weaker
than in the presence of APS. Samples 7 and 8 contain no Ruthenium or APS and display the
same bands as lanes 4-7. Sample 9 contains all reactants and has the strongest ladder of bands.
It is obvious that in the absence of APS (sample 6) crosslinking is not as efficient as in the
presence of the electron acceptor (sample 9) because the intensity and amount of the bands are
decreased.
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Figure 19: An experiment confirming the validity of the PICUP reaction by sequentially testing
the importance of each reaction component for capturing oligomeric species of Aβ1-42 and
running the samples on a 16.5% Tris tricine gel. Each lane alternates no light and 1 second of
exposure. The lane containing Aβ, Ru, APS, and 1 second of light shows the most distinct
ladder of Aβ1-42 species.

Once the correct reactant ratio was determined, Aβ1-42 was aggregated at 800 rpm for 2
hours. A sample was taken every 15 minutes and subjected to PICUP. The results are shown in
Figure 20. At every time point, a ladder of protein sizes are present. At 0 minutes of
aggregation, the majority of the protein detected is between 2 kDa and about 8 kDa. At 120
minutes, the majority of the protein detected is between 2 kDa and 5 kDa. The amount of protein
in each lane gradually decreases as time progresses, suggesting that very large aggregates are
being made and likely caught at the top of the gel.
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Figure 20: Aβ1-42 aggregated at 800 rpm subjected to PICUP analyzed on a 16.5% Tris-tricine
gel. The left most lane contains protein molecular weight standards. Each following lane
analyzes the time of aggregation prior to PICUP.

In order to detect the higher molecular weight species formed after two hours of
aggregation, PICUP was analyzed on a 12.5% Tris-glycine gel. Results are shown in Figure 20.
Similar to the 16.5% Tris-tricine gel, the majority of protein detected is found between 2 kDa
and 8 kDa at 0 minutes to 2 kDa and 5 kDa at 120 minutes. No additional higher molecular
weight species were found when compared to the 16.5% Tris-tricine gel. It is possible that after
two hours of aggregation, Aβ1-42 species has a molecular weight higher than 50 kDa and bands
exist that are not seen. This could be tested by running the gel for longer than 2.5 hours and
possibly letting the smaller molecular weight bands to travel off of the gel. Also, the samples
could be analyzed with CE and to see if peaks come out after the normal run time of 30 minutes.
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Figure 21: Aβ1-42 aggregated at 800 rpm subjected to PICUP analyzed on a 12.5% Tris-glycine
gel. The left most lane contains protein molecular weight standards. Each following lane
analyzes the time of aggregation prior to PICUP. The higher molecular weight species are more
separated in the 12.5% Tris-glycine gel versus the 16.5% Tris-tricine gel. Therefore, this gel
should more optimally show higher molecular weight species.

In order to analyze the samples via CE, control samples containing each reactant at the
appropriate final concentration were run to ensure no reactant absorbs UV light at 214 nm and
causes interference for detecting the protein. Since the final concentration of Aβ1-42 is low (3.33
µM), the protein must be electrokinetically injected for 15 seconds, which preferentially injects
charged groups into the capillary to be detected. Figure 22 shows the results of electrokinetically
injecting Ruthenium, APS, Co(III), Dithiothreitol (DTT), and 5% β-Mercaptoethanol separately.
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Figure 22: All potential PICUP reactants are shown in the above electropherogram. All
reactants relate to the vertical axis on the left except APS. Ruthenium does not absorb UV light
at 214nm. The potential electron acceptors, APS and Cobalt (III), both absorb UV light. APS
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creates a peak around 2.5 minutes that masks Aβ1-42 oligomers. Cobalt portrays multiple peaks.
The potential quenching agents, β-Mercaptoethanol and DTT, create noisy data and are unusable
in samples to detect Aβ1-42 oligomers.

Ruthenium does not absorb UV light at 214 nm and is acceptable to use in samples with
Aβ1-42. The electron acceptor, APS has a predictable peak that is detected around 2.5 minutes.
However, the location of this peak masks oligomeric Aβ1-42 species, so it would be beneficial to
remove APS. Therefore, a Co (III) solution was tested as a potential electron acceptor instead of
APS. Co (III) was chosen as an alternative electron acceptor because it is a water-soluble metal
ion complex willing to donate an electron under the correct conditions.(35) Vollers et al.
performed PICUP reactions with Aβ1-42 and noted that Co (III) could be a possible alternative.
The efficiency of Co (III) as a potential electron acceptor was tested by performing a PICUP
experiment and replacing the APS with Co (III) and analyzing the samples on a 16.5% Tris
tricine gel, these results are shown in Figure 23. Additionally, Co (III) was electrokinetically
injected to test its UV absorption at 214 nm, these results are shown in Figure 22.
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Figure 23: Aβ1-42 aggregated at 800 rpm subjected to PICUP using Co(III) rather than APS as an
electron acceptor and analyzed on a 16.5% Tris-tricine gel. The left most lane contains protein
molecular weight standards. Each following lane analyzes the time of aggregation prior to
PICUP.

Comparing Figure 23, which uses Co (III) as an electron acceptor, and Figure 20, which
uses APS as an electron acceptor, it is clear that APS captured more transient species of Aβ1-42 by
the number of bands represented on the gel. Additionally, the Co (III) would not stay in solution,
causing the band between 2 and 5 kDa to have a wavy effect. Co (III) was also analyzed by CE
to determine if it absorbs light at 214 nm at the appropriate concentration. Looking at Figure 22,
it is clear that Co (III) does absorb UV light by the peak around 2 minutes. Therefore, Co (III)
was determined to not be an acceptable alternative electron acceptor in PICUP applications with
Aβ1-42. No other electron acceptors were tested.
Additionally, both quenching agents greatly interfere with protein detection. βMercaptoethanol and DTT create noisy data and their presence in samples after PICUP inhibits
the ability to precisely detect protein using CE over the entire time period of detection. In order
to detect Aβ1-42 PICUP samples on via CE, β-Mercaptoethanol and DTT should not also be
present in the sample. No other quenching agents were tested.
In order to overcome the inability of PICUP agents to be used in Aβ1-42 samples for CE
analysis two methods were tested. The first method used 2000 kDa filters and 100 mM
phosphate for dialysis, similar to the separation conditions using CE. The filter size of 2000 kDa
was chosen due to the large discrepancy between the molecular weight of Aβ1-42 and the PICUP
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reagents. Aβ1-42 has a molecular weight of 4514.06 Da; APS, Ruthenium, and βMercaptoethanol have molecular weights of 228.18 g/mol, 748.62 g/mol, 78.13 g/mol,
respectively. A 2000 kDa filter was considered an appropriate size to release the reagents while
retaining Aβ1-42. The PICUP reaction proceeded as follows: 4 µL of 20 µM Aβ1-42 was added to 4
µL of 200 µM APS and 4 µL of 10 µM Ruthenium then subjected to 1 second of Xenon light.
Afterwards, the reaction was quenched with 12 µL of 5% β-Mercaptoethanol in 10 mM
phosphate buffer. The sample was then allowed to filter through a 2000 kDa membrane for 24
hours. The phosphate buffer was changed every two hours for the first 10 hours then left
overnight. Figure 24 shows the resulting Tris-tricine gel for dialysis samples and Figure 25
shows CE analysis for dialysis samples. Figure 26 shows a closer view of Figure 25.

	
  

49

37	
  kDa	
  
25	
  kDa	
  
20	
  kDa	
  
15	
  kDa	
  
10	
  kDa	
  

5
4
3

5	
  kDa	
  

2
1

2	
  kDa	
  

Sample	
  	
  	
  	
  	
  1	
  	
  	
  	
  	
  	
  2	
  	
  	
  	
  	
  	
  	
  3	
  	
  	
  	
  	
  	
  4	
  	
  	
  	
  	
  	
  	
  5	
  	
  	
  	
  	
  	
  	
  	
  6	
  	
  	
  	
  	
  	
  	
  	
  7	
  	
  	
  	
  	
  	
  	
  	
  	
  8	
  
Time	
  	
  	
  	
  	
  	
  	
  	
  	
  0	
  	
  	
  	
  	
  	
  0	
  	
  	
  	
  	
  	
  45	
  	
  	
  	
  45	
  	
  	
  	
  75	
  	
  	
  	
  	
  	
  75	
  	
  	
  	
  	
  120	
  	
  	
  120	
  
Dialysis	
  	
  	
  	
  -‐	
  	
  	
  	
  	
  	
  	
  +	
  	
  	
  	
  	
  	
  	
  -‐	
  	
  	
  	
  	
  	
  	
  +	
  	
  	
  	
  	
  	
  	
  -‐	
  	
  	
  	
  	
  	
  	
  	
  	
  +	
  	
  	
  	
  	
  	
  	
  	
  	
  -‐	
  	
  	
  	
  	
  	
  	
  	
  	
  +	
  	
  	
  	
  	
  
Figure 24: 	
  Samples 1, 3, 5, and 7 are PICUP samples that did not undergo dialysis. Samples 2,
4, 6, and 8 did undergo 24 hours of dialysis to remove the APS and 5% β-Mercaptoethanol. The
lanes that underwent dialysis show some protein loss, but dialysis did not alter the conformation
captured during PICUP.
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Figure 25: The aggregation pathway of Aβ1-42 analyzed via CE after a 2 hour aggregation at 800
rpm and 24 hours of dialysis to remove APS and 5% β -Mercaptoethanol. Generally, more
species are present after more aggregation.
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Figure 26: The aggregation pathway of Aβ1-42 analyzed via CE after a 2 hour aggregation at 800
rpm and 24 hours of dialysis to remove APS and 5% β -Mercaptoethanol. This is the same data
as Figure 25, but with a closer view of initial peaks detected by CE.

Figure 24 shows that dialysis does not alter the Aβ1-42 conformation captured using
PICUP because the same bands are present in each sample taken at the same time point.
However, the bands for samples 2, 4, 6, and 8 are not as intense, showing protein loss during
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dialysis. Figure 25 shows that the majority of APS and 5% β-Mercaptoethanol appears to have
been successfully removed using dialysis since the peaks present in the samples do not correlate
with the individual reagents (Figure 22). However, Figure 26 shows that there does seem to be
residual APS in the 0 minute aggregation sample and residual β -Mercaptoethanol in the 120
minute aggregation sample. Therefore, the dialysis procedure could use some further
modification to achieve greater consistency of maximizing protein retention and reactant loss
across samples. Figure 26 also shows that the longer Aβ1-42 is aggregated, the more distinct
species are present. These peaks mainly elute between 2-4 minutes. From Figure 26, it looks as
if the 0 minutes sample still contained residual APS given the large peak at 1 minute. For this
sample, dialysis was not as efficient since the other samples do not contain this peak. For 0
minutes, it is likely that APS is masking the Aβ1-42 and real peaks of monomeric protein cannot
be seen. The 45 minute, 75 minute, and 120 minute samples all have a strong consistent peak
after 2 minutes. Similarly, the same samples have a strong, consistent band between 2 and 5
kDa. It is hypothesized that the peak eluted after 2 minutes correlates with the first band in each
sample. The 45 minute sample has a strong peak just after 1 minute that is not located in any
other sample. There are no definite conclusions able to be drawn from which band this could
correlate to since there are many bands that are stronger in the 45 minute sample than the 75
minute and 120 minute, and the 0 minute CE sample is not a credible reference. It looks as
though dialysis was most efficient for the 75 minute sample due to the sharp separation of peaks.
The 5 peaks shown for the 75 minute sample could correlate to the 5 bands shown on the gel.
The 120 minute sample additionally looks as though dialysis wasn’t as efficient due to the large
wide peak before 3 minutes. This could be caused by residual β –Mercaptoethanol. The Aβ1-42
detection via CE was heavily dialysis dependent, as seen by the differences in the 0 minute and
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75 minute samples. This experiment was repeated twice more, but as the samples within this
experiment relied heavily on dialysis efficiency, the other results did as well. This caused the
results to not be consistent within each time point or within each experiment. However, as seen
from the 75 minute sample, dialysis could be a promising method to removing the PICUP
reagents and detecting Aβ1-42 if the procedure could be made more consistent.
The second method used to detect Aβ1-42 via CE analysis without interfering PICUP
reactants involved removing APS and β –Mercaptoethanol completely. Aβ1-42 was subjected to
Ruthenium and light, then quenched by freezing the sample at -80°C. No electron acceptor or
chemical quenching agent was used. This means an oxygen radical was generated in the PICUP
reaction and subsequently only the most easily oxidized species were cross-linked.
Shown in Figure 27, a 16.5% Tris-tricine gel was used to analyze PICUP without APS.
A ladder of protein bands was not shown after silver staining. The band locations are identical to
the locations in Figure 19, when APS is not present and in Figure 18 using the unoptimized
PICUP reagent ratio. However, taking into account the results from CE (Figures 28 and 29) as
described below, it is possible that the PICUP reaction occurred, but not as efficiently as it would
have in the presence of APS.
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Figure 27: Aβ1-42 aggregated at 800 rpm subjected to PICUP without APS analyzed on a 16.5%
Tris-tricine gel. The left most lane contains protein molecular weight standards. Each following
lane analyzes the time of aggregation prior to PICUP.

Figures 28 and 29 display the same samples as Figure 26 analyzed by capillary
electrophoresis. Figure 28 displays there are a multitude of peaks between 0 and 4 minutes.
Figure 29 shows a closer look at the species detected between 0 and 4 minutes. At 0 minutes,
there is one large peak just before 2 minutes. This peak grows until the 60 minute sample, where
it is absent and replaced by four smaller peaks. The four smaller peaks become six small peaks
in the 75 minute sample. The six small peaks become three larger peaks in the 90 minute
sample. After 90 minutes, the peaks grow in area until 120 minutes. No testing was done after
120 minutes of aggregation. The samples analyzed by CE and a Tris-tricine gel, Figures 27 and
28 respectively, do not correlate. This could be due to the fact that CE is more sensitive and has
a lower limit of detection than Tris-tricine gels.
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Figure 28: Aβ1-42 was aggregated at 800 rpm for 2 hours. A sample was taken every 15 minutes
and subjected to Ru(bpy)3 and 1 second of Xenon light. The reaction was quenched by placing
the sample in the freezer. Each sample was analyzed by CE. Each peak corresponds to protein
detection at 214 nm.
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Figure 29: Replication of Figure 19, zoomed in to see a closer view of the initial peaks of the
samples. Aβ1-42 was aggregated at 800 rpm for 2 hours. A sample was taken every 15 minutes
and subjected to Ru(bpy)3 and 1 second of Xenon light. The reaction was quenched by placing
the sample in the freezer. Each sample was analyzed by CE. Each peak corresponds to protein
detection at 214 nm.

It is questionable that Figures 26 and 28 show different peaks of Aβ1-42 after the same
aggregation time period. This is likely due to a loss of protein during the dialysis process and
inadequate removal of PICUP reactants during dialysis. Presence of APS and β-Mercaptoethanol
mask Aβ1-42 and an adequate comparison cannot be made between Figures 26 and 28 due to this.
Ultimately, capillary electrophoresis is a more sensitive method to detect Aβ1-42 species when
compared to Tris-tricine gels. However, tris-tricine gel analysis takes about 9 hours to analyze 9
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samples and CE analysis takes about 13 hours to analyze 9 samples, so this should be taken into
account when deciding how to analyze PICUP reactions. Overall, CE analysis shows the amount
of Aβ1-42 species increases as aggregation time increases with peaks occurring mainly between 0
and 5 minutes. Tris-tricine analysis shows that Aβ1-42 species decrease between 2 and 37 kDa,
but it is likely that higher molecular weight species are forming and cannot be seen.
PICUP and removal of reactants via dialysis was performed three-peat. Unfortunately,
the results were limited by the efficiency of dialysis; many of the samples still had residual
reactants. This coupled with the loss of protein compromised the visibility of Aβ1-42 peaks. The
Hestekin lab was unable to distinctly correlate bands on a Tris-tricine gel to peaks via CE
analysis due to this inefficiency. However, when dialysis efficiency was high, CE was a valid
method to analyze PICUP samples. Additional experiments should be performed to make
dialysis a more consistent method of removing PICUP reactants to greatly affect CE analysis of
Aβ1-42 aggregates. Also, more experiments should be performed to confirm the reason for the
difference in CE analysis for samples after dialysis and samples not including APS and βMercaptoethanol. It would be preferable to perform dialysis rather than eliminate APS as a
reactant because its inclusion ensures the most efficient capture of Aβ1-42 oligomers. Ultimately,
CE is an acceptable method for analysis of PICUP samples that is more sensitive than Tristricine gels.
Conclusions and Future Directions
A device available worldwide that could enhance Aβ1-42 studies would benefit the
Alzheimer’s research community. A device that can detect Aβ1-42 at a picomolar level and
separate metastable species would allow for study of its aggregation pathway and provide a
breadth of knowledge about AD. Optimizing the recovery of Aβ1-42 recovery in capillaries by
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coating them with a hydrophilic polymer would translate to this device. 2000kDa PEO provided
the best recovery at 87% compared to an uncoated capillary recovery of 67%. Further
investigation needs to be done for reproducibility.
Studying Aβ1-42 after PICUP application with CE could provide insight to its aggregation
pathway because CE has the ability to provide high resolution analysis of photo-crosslinked
aggregated Aβ1-42. These results could provide a toolset to help researchers develop a new way
to study this protein since it’s metastable nature causes difficulty in obtaining reproducible
results. From the experiments conducted by the Hestekin lab, other researchers can use CE and
obtain the specific molecular weight of Aβ1-42 species present along the aggregation pathway.
Further, if the toxicity of these species was dependent upon the molecular weight a drug could be
designed to block or eliminate these species, in order to slow, prevent, or cure Alzheimer’s
disease.
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Appendix
Monomerization by HFIP and storage of Aβ1-42 Stock Solutions:
1. Aβ1-42 is stored as a solid at -80C. Remove and place on ice when ready to
prepare stock peptide films.
2. Place 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) on ice in the hood and allow to
cool. HFIP is highly corrosive and very volatile. Add enough HFIP to Aβ1-42
such that the final peptide concentration is 1mM (e.g. 221.53 ul cold HFIP to 1
mg Aβ1-42). Rinse vial thoroughly.
3. Incubate at room temperature for 60 min, keeping vial closed. Solution should be
clear and colorless. Any traces of yellow color or cloudy suspension indicate poor
peptide quality and should not be used.
4. Separate the HFIP into vials with 0.0271 mg/vial. That means each vial has 6 µL
stock.
5. Aliquot solution into non-siliconized microcentrifuge tubes. Do not close tubes.
6. Allow HFIP to evaporate overnight in the hood at room temperature.
7. All traces of HFIP must be removed. The resulting peptide should be a thin clear
film at the bottom of the tubes. The peptide should not be white or chunky.
8. Store dried peptide films over desiccant at -80C. These stocks should be stable for
several
months.
Phosphate Buffer Preparation .1M, pH=7.4
1. Add 19mL of .2M monobasic sodium phosphate
2. Add 81mL of .2M dibasic sodium phosphate
3. Dilute to a total 200mL.
Sample Preparation
1. Retrieve vial with .0271mg of Aβ1-42 from the -80oC freezer.
2. Prepare 20µM concentration by adding 15µL of 5mM NaOH.
3. Let dissolve for 5 minutes.
4. Add 285µL of 10mM phosphate buffer.
5. Let dissolve for 15 minutes.
6. If aggregating, place on shaker at 800rpm and 25oC.
CE Protocol
1. Cut capillary to 31cm using device.
2. Coat capillary using following sequence:
1. Rinse for 20 minutes with .1M NaOH at 50psi.
2. Rinse for 20 minutes with water at 20psi.
3. Rinse for 60 minutes with .1M HCl at 20psi.
4. Rinse for 10 minutes with water at 20psi.
5. Rinse for 15 minutes with water at 20psi.
6. Rinse for 15 minutes with .1M HCl at 20psi.
7. Rinse for 30 minutes with coating polymer at 50psi.
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3.

4.

5.

6.

8. Rinse for 15 minutes with water at 20psi.
9. Rinse for 10 minutes with .1M phosphate buffer at 20psi.
10. Rinse for 10 minutes with water at 50psi.
11. Rinse for 10 minutes with .1M phosphate buffer at 50psi.
For coating study reverse runs:
1. Rinse for 5 minutes with .1M phosphate buffer at 50psi.
2. Inject sample for 8 seconds at 0.5psi.
3. Separate for 30 minutes at 7kV with a .17 minute ramp.
For coating study forward runs:
1. Rinse for 5 minutes with .1M phosphate buffer at 50psi.
2. Inject sample for 8 seconds at 0.5psi.
3. Separate for 60 minutes at 7kV with a .17 minute ramp.
For PICUP samples:
1. Rinse for 5 minutes with .1M phosphate buffer at 50psi.
2. Inject sample for 15 seconds at 10.0kV.
3. Separate for 30 minutes at 7kV with a .17 minute ramp.
All sample runs separated by the following wash:
1. Rinse for 10 minutes with water at 50psi.
2. Rinse for 10 minutes with .1M phosphate buffer at 50psi.

PICUP Protocol
1. Align camera, phototube and light source. Set camera to setting 1.
2. Add 4µL of 20µM Aβ1-42 to a non-stick microcentrifuge tube.
3. Add 4µL of 10mM Ru(bpy)3.
4. Add 4µL of 200mM APS.
5. Insert tube in front of camera.
6. Press shutter to expose sample to light.
7. Quickly add 10µL of 5% β-mercaptoethanol.
16.5%Tris-Tricine Gel Protocol
1. Set up glass plates in Bio-Rad device.
2. Add 80mL of 30% acrylamide, 2.75mL 1.25M TrisCl pH=8.8, .95mL diH2O, and
50µL 10% SDS.
3. Quickly add 150µL of 10% APS and 12µL TEMED. Pipet between the glass
plates.
4. Pipet a layer of butanol on top of solution.
5. When the gel is polymerized, remove the butanol and replace with spacer.
6. Add 415µL of 30% acrylamide, 630µL of .5M TrisCl pH=6.8, 1.385mL of diH2O,
and 0.025mL of 10%SDS.
7. Quickly add 75µL of 10% APS and 12µL TEMED. Wait for the gel to
polymerize.
8. Place the gel in a 1X Tris-Tricine Running Buffer.
9. Add 7µL of standards and 22µL of sample in the lanes.
12.5% Tris-Glycine Gel Protocol
1. Set up glass plates in Bio-Rad device.
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2. Add 2.1mL of 30% acrylamide, .65mL 1.5M TrisCl pH=8.8, 1.55mL diH2O, and
.7mL of 75% Sucrose.
3. Quickly add 50µL of 10% APS and 3µL TEMED. Pipet between the glass plates.
4. Pipet a layer of butanol on top of solution.
5. When the gel is polymerized, remove the butanol and replace with spacer.
6. Add .375mL of 30% acrylamide, .625mL of .5M TrisCl pH=6.8, and 1.5mL of
diH2O.
7. Quickly add 22.5µL of 10% APS and 11µL TEMED. Wait for the gel to
polymerize.
8. Place the gel in a 1X Tris-Glycine Running Buffer.
9. Add 7µL of standards and 22µL of sample in the lanes.
Silver Stain Protocol
1. Let gel soak in fixing solution and shake for 60 minutes. (7.5mL ethanol, 2.5mL
glacial acetic acid, water to 25mL).
2. Remove the solution. Let gel soak in sensitizing solution and shake for 1 hour up
to 24 hours. (7.5mL ethanol, 1mL sodium thiosulfate, 1.7g sodium acetate, water
to 25mL, add 125µL glutaraldehyde before use)
3. Remove the solution. Let gel soak in water three times and shake for 15 minutes
each time.
4. Remove the solution. Let gel soak in silver solution and shake for 1 hour. (2.5mL
silver nitrate solution, water to 25 mL)
5. Remove the solution. Let gel soak in water twice and shake for 1 minute each
time.
6. Remove the solution. Let gel soak in developing solution and shake for 4-6
minutes. (.625g sodium carbonate, water to 25mL, add 20µL of formaldehyde)
7. Remove the solution. Let gel soak in stop solution. (.365g EDTA solution, water
to 25mL)
8. Remove gel from solution and scan.
Matlab Code
%This is a function that takes the outpout of the 32 Karat program and
%turns the output into time, absorbance, voltage, and current. Then
%located peaks from the data and from each peak the molecular weight.
d=input('Was Walter run in reverse (1) or forward (2)?');
if d==1
Ld=10;
%Length to detector, cm
elseif d==2
Ld=21;
else
disp('Error d must equal 1 or 2.');
end
Lt=.31/100;
%Total length of capillary, cm
AB=input('Are you using Amyloid Beta 40 or 42?');
if AB == 40
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mu_o=13;
%Mobility in free buffer
Vm=.7362;
%Partial specific Volume, cm^3 g^-1
elseif AB == 42
mu_o=13;
Vm=.7362;
else disp ('Error AB must be of 40 or 42 amino acids.')
end
phi=input('What is the polymer concetration (wt%)?');
if phi > 4
disp('Concentration must be between 0 and 4 %.');
elseif phi <0
disp('Concentration must be between 0 and 4 %.');
end
%% Part 1: Analyze data into matrices of Time, AU, kV, uA
%Ask for file to manipulate into Absorbance and Current data.
[FileName, PathName]=uigetfile('*.xlsx') ;
%Translate data into a numerical array.
[num]=xlsread(FileName);
%Translate numerical array into 4 column matrices of data.
A=num(:,1);
B=num(1:13,2);
C=num(1:13,3);
D=num(1:13,3);
%Create time matrix from imported data.
Rate=B(8);
TotalPts=B(9);
Xmult=B(12);
s=Xmult/Rate;
t=[s:s:s*TotalPts]';
%Separate column A into three separate matrices for Absorbance, Voltage,
%and Current, repectively.
A1=A(14:B(9)+13);
B1=A(B(9)+14:B(9)+C(9)+13);
C1=A(B(9)+C(9)+14:B(9)+C(9)+D(9)+13);
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%Calculate Absorbance, Voltage, and Current.
AU=A1*B(13);
kV=B1*C(13);
uA=C1*D(13);
%Plot Absorbance and Current versus time on same plot.
[AX,H1,H2]=plotyy(t,AU,t,uA);
title (FileName);
xlabel ('Time(minutes)');
ylabel (AX(1),'Absorbance (AU)');
ylabel (AX(2),'Current (\muA)');
legend('Absorbance','Current');
set(AX(2),'XTickLabel','','XAxisLocation','Top'); %Make top label.
set(AX(1),'ylim',[min(AU) max(AU)]);
%Set left y limits.
set(AX(2),'ylim',[min(uA) max(uA)]);
%Set right y limits.
set(AX(1),'xlim',[t(1) t(end)]);
%Set left x limits.
set(AX(2),'xlim',[t(1) t(end)]);
%Set right x limits.
set(AX(1),'box','off')
%Turn off left y limits showing on right y.
set(AX(1),'ytick',linspace(min(AU),max(AU),10)) %Display 10 ticks on left y axis.
set(AX(2),'ytick',linspace(min(uA),max(uA),5)) %Display 5 ticks on right y axis.
%% Part 2 Reduce noise, correct baseline, identify peaks
[p,c,mu]=polyfit(t,AU,40);
%Fit electropherogram to a 40th order polynomial
AU1=polyval(p,t,AU,mu);
%Detrend fit from polynomial
AUcorr=AU-AU1;
%Electropherogram with corrected baseline
WT=ndwt(AUcorr,10,'db8');
%Apply Daubauchies8 wavelet transform, Level 10
AUa=indwt(WT,'a',1);
%Reconstruct low pass content
AUd=indwt(WT,'d',1);
%Reconstruct high pass content
erra=max(abs(AU(:)-AUa(:)));
%Calculate the error Wavelet
noise=max(AUd)-min(AUd);
%Calculate the noise taken from the data
figure();
%Create new plot
plot(t,AUa);
title (FileName);
xlabel ('Time (minutes)');
ylabel ('Absorbance (AU)');
xlim ([t(1) t(end)]);
ylim ([min(AUa) max(AUa)]);
%Find the peaks that are 30*hight of noise value and at least 25 data
%points apart. Plot the found peaks with markers on the Absorbance graph
%with noise removed.
[ph,ploc]=findpeaks(AUa,'minpeakheight',30*noise, 'minpeakdistance',25);
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hold on;
plot(t(ploc),ph,'k^','markerfacecolor',[1 0 0]);
hold off;
tm=t(ploc);
%Create a time matrix of the found peaks

figure()
%Plot the Absorbance before and after noise removal on
same figure
subplot(211)
plot(t,AUcorr)
title ('Absorbance before noise removal')
xlabel ('Time (minutes)');
ylabel ('Absorbance (AU)');
xlim ([t(1) t(end)]);
ylim ([min(AUcorr) max(AUcorr)]);
subplot(212)
plot(t,AUa)
title ('Absorbance after noise removal')
xlabel ('Time (minutes)');
ylabel ('Absorbance (AU)');
xlim ([t(1) t(end)]);
ylim ([min(AUa) max(AUa)]);
%% Part 3 Calculate molecular weight.
V=mean(kV);

%Calculate applied voltage (kV)

%Create Ferguson plot
muf=[13 9 8 7 6];
%Ferguson plot, mobility
mu_of=13;
%Ferguson plot, free mobility
phif=[0 1 2 3 4];
%Ferguson plot, polymer concentration
figure();
%Create Ferguson Plot
plot(phif,log10(muf/mu_of));
title 'Ferguson Plot Amyloid Beta 1-42';
xlabel 'Polymer Concentration (%)';
ylabel 'Mobility log(\mu/\muo)';
for i=1:length(tm);
%Calculate the mobility of each peak
mu(i)=((Ld*Lt)/V)*(1/tm(i));
i=i+1;
end;
for j=1:length(mu);
%Create a matrix of phi for each peak
phim(j)=phi;
j=j+1;
end;
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hold on;
plot(phim,mu,'k^','markerfacecolor',[1 0 0]); %Plot each peak on Ferguson plot
KR=(-log10(mu/mu_o))/phi;
%Protein retardation coefficient
l=1000*10^-7;
%Total length of polymer fiber/volume, cm^-2
r=250*10^-7;
%Polymer fiber radius, cm
R=sqrt(KR/(pi*l*10^-16))-r;
%Protein radius, cm
N=6.0221413*10^23;
%Avogadros number
Mw=(R/10^7).^3*((4*pi*N)/(3*Vm));
%Molecular weight, Da
VN={'MigrationTime' 'Mobility' 'Radius' 'MW'};
Data=table(tm,mu,R,Mw,'VariableNames',VN);
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